Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

blue earth diagnostics ireland ltd - fluciclovine (18f) - prostatic neoplasms; radionuclide imaging - diagnostiske radiopharmaceuticals - dette legemidlet er kun til diagnostisk bruk. axumin er indikert for positron emisjon tomografi (pet) bildebehandling for å oppdage tilbakefall av prostata kreft hos voksne menn med en mistanke om tilbakefall basert på forhøyet blod prostata spesifikt antigen (psa) nivåer etter primær kurativ behandling.

Նորվեգիա - Նորվեգերեն - Adama

adama - florasulam 2,5 g/l (0,25 vikt-%) + fluroksypyr-1-metylheptylester 144 g/l (14.2 vikt-%) - ugrasmiddel

Նորվեգիա - Նորվեգերեն - Adama

adama - florasulam 2,5 g/l (0,25 vikt-%) + fluroksypyr-1-metylheptylester 144 g/l (14.2 vikt-%) - ugrasmiddel

Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiske midler - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

3m health care limited - rivastigmin - alzheimers sykdom - psychoanaleptics, , anticholinesterases - symptomatisk behandling av mild til moderat alvorlig alzheimers demens.

Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantelcelle - antineoplastiske midler - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

ge healthcare ltd - krom (51cr) edetat - injeksjonsvæske, oppløsning - 3.7 mbq/ ml

Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

ge healthcare b.v. - natriumjodid (123i) - kapsel, hard

Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

ge healthcare b.v. - natriumjodid (123i) - injeksjonsvæske, oppløsning - 37 mbq/ ml

Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

ge healthcare buchler gmbh & co. kg - natriumjodid (131i) - kapsel, hard - 3.7 mbq